Local News: Seattle, WA 

 | 

Sign Up

 | 

Sign In

Eli Lilly News Editors

News Widget

Display the Eli Lilly news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Eli Lilly News

News on Eli Lilly (Ticker: LLY) continually updated from thousands of sources around the net.

Thursday May 16 | Indianapolis Business News

Canada's Supreme Court won't hear Lilly appeal on Zyprexa

Canada's Supreme Court dismissed Eli Lilly and Co.'s request to appeal a federal court decision that invalidated its Canadian patent for schizophrenia drug Zyprexa.

Comment?

Related Topix: Alnara Pharmaceuticals, Biotech, Food, Medicine, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Eli Lilly, Imclone Systems, Healthcare Industry

Wed May 15, 2013

The Motley Fool

These Stocks Are Still Solid Long-Term Picks

Jarrod is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited.

Comment?

Related Topix: Financial Markets, Blog News, Biotech, Eli Lilly, Medicine, Healthcare Industry

Thu May 09, 2013

Drug Store News

Former Eli Lilly executive appointed to top technology post at Sears Holdings

Balagna was previously chief information officer for drug maker Eli Lilly and will be responsible for Sears Holdings' technology and infrastructure initiatives in its support centers and in-store. "Jeff is a proven executive with an analytic approach and experience in transforming complex organizations in rapidly evolving industries," Sears ... (more)

Comment?

Related Topix: Sears Holdings Corporation, Biotech, Eli Lilly, Medicine, Healthcare Industry, CIO News

Wed May 08, 2013

I-Newswire.com

Brain League IP Services Adds a New Director to Its Board.

In a recent strategic move, Brain League added Mr. Erik Ramanathan to its board of directors.

Comment?

Related Topix: Imclone Systems, World News, India, Cupertino, CA, Marketing

Tue May 07, 2013

National Center for Public Policy Res...

More on Eli Lilly and ObamaCare...

Eli Lilly CEO Dr. John Lechleiter Says Obama Administration "Dual-Eligibles" Rebate Plan Would Lead to "Catastrophic Consequences" for Innovation Industry Could Face More than $100 Billion in Extra Costs Under President's Plan, Lechleiter Says, in Response to Questioning from National Center for Public Policy Research Patients with Private ... (more)

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Healthcare Law, Law, Medicare, Health, Indianapolis, IN

BioSpace

Eli Lilly and Company Job Cuts Almost Double Original Numbers in Detailed Report

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Eli Lilly and Co.'s massive restructuring of its sales force will affect more employees than the Indianapolis-based drugmaker disclosed in early April.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Alnara Pharmaceuticals, Food, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Imclone Systems

BioSpace

Eli Lilly and Company Declares Second-Quarter 2013 Dividend

Headquartered in , Lilly provides answers through medicines and information for some of the world's most urgent medical needs.

Comment?

Related Topix: Biotech, Eli Lilly, Medicine, Healthcare Industry

Mon May 06, 2013

KHOU-TV Houston

Eli Lilly: CEO Lechleiter will have aorta surgery

Drugmaker Eli Lilly & Co. said Tuesday that President, CEO and Chairman John Lechleiter will have surgery for a dilated aorta on Monday.

Comment?

Related Topix: Biotech, Eli Lilly, Medicine, Healthcare Industry

GlobeNewswire

Send Press Releases with GlobeNewswire

Effective November 12, 1998, Chrysler common stock will be excluded from the Wilshire 5000 Index.

Comment?

Related Topix: Downtown (Los Angeles, CA), Emmy Awards, Entertainment, Television, Depression, Health

Tue Apr 30, 2013

BioSpace

Nuvilex Pancreatic Cancer Trials Could Make "Cell-in-a-Box" Gold Standard

While many biotech and pharmaceutical companies are designing one drug after another to address specific health problems, Nuvilex, Inc.

Comment?

Related Topix: Pancreatic Cancer, Health, Biotech, Medicine, Eli Lilly, Healthcare Industry, Celgene

Fri Apr 26, 2013

The Motley Fool

Is a Pharmaceutical Company the Same as a Biotech?

"Pharmaceutical company" and "biotech" are terms that investors hear all the time -- but what's the difference? Are they essentially the same thing, or are they two entirely different types of drugmakers? The answer is more confusing that you may think.

Comment?

Business Wire

Fitch Rates Indianapolis Bond Bank, IN's Downtown TIF Rev Bonds 'AA'; Outlook Stable

Proceeds will be used to refund outstanding series 2002G bonds and to finance various capital projects.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry

The Indianapolis Star

Eli Lilly workers volunteer overseas to help impoverished communities

The first of 200 Eli Lilly and Co. employees shipped out this week to take part in Lilly’s in-house version of the Peace Corps.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry

BioSpace

Adocia Announces Its Q1 2013 Revenues

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Lyon, France, April 24, 2013 - Adocia , a biotechnology company specialized in the development of 'best-in-class' medicines from already approved therapeutic proteins, announces today its Q1 2013 revenues.

Comment?

Related Topix: Adocia, France, World News, Biotech, Science / Technology, Medicine, Insulin (generic), Humulin, Novolin, Diabetes, Health

Thu Apr 25, 2013

AmericanBankingNews.com

Eli Lilly & Co.'s Neutral Rating Reaffirmed at Zacks

's stock had its "neutral" rating reiterated by Zacks in a note issued to investors on Thursday, Stock Ratings Network reports.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Alnara Pharmaceuticals, Food, Avid Radiopharmaceuticals, Agriculture, International Multifoods Corporation, Imclone Systems

BioSpace

Eli Lilly and Company Again Named One of s Top 50 Companies for Diversity

DiversityInc 's "Top 50 Companies for Diversity" is known as a leading assessment of diversity management globally.

Comment?

Related Topix: Biotech, Eli Lilly, Medicine, Healthcare Industry

The Jersey Journal

Eli Lilly sues J&J for patent rights in Alzheimer's drug race

Eli Lilly & Co. sought to revoke a patent held by a Johnson & Johnson unit, arguing at a London court it might delay availability of a potential treatment for Alzheimer's. Both companies have drugs in development that use antibodies to target the build-up of plaque in patients' brains.

Comment?

Related Topix: Alzheimer's, Health, Food, J and J Snack Foods, Biotech, Medicine, Eli Lilly, Healthcare Industry, Johnson & Johnson, Johnson and Johnson

Wed Apr 24, 2013

Star Tribune

Disappointing earnings and weak sales outlooks hold stocks back; P&G and Eli Lilly fall

A subscriber slump at AT&T and a poor profit forecast at Procter & Gamble were among the disappointments investors were dealing with Wednesday.

Comment?

Related Topix: Biotech, Medicine, Financial Markets, Eli Lilly, Healthcare Industry

Seattle Jobs